Lu, Xinchang <br/><br/>
Sorafenib induces growth inhibition and apoptosis of human chondrosarcoma cells by blocking the RAF/ERK/MEK pathway.  [electronic resource] 

 -  Journal of surgical oncology  Dec 2010 
 - 821-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-9098 
<br/><br/><label>Standard No.: </label>10.1002/jso.21661  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Apoptosis Regulatory Proteins--metabolism<br/>Benzenesulfonates--pharmacology<br/>Blotting, Western<br/>Bone Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Chondrosarcoma--drug therapy<br/>Cyclin D1--metabolism<br/>Extracellular Signal-Regulated MAP Kinases--antagonists & inhibitors<br/>Humans<br/>Mitogen-Activated Protein Kinase Kinases--antagonists & inhibitors<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Phosphorylation--drug effects<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Pyridines--pharmacology<br/>Signal Transduction--drug effects<br/>Sorafenib<br/>raf Kinases--antagonists & inhibitors